These Weight Loss Medicines and Diabetes Should Warn of Serious Damage to Vision

DiarioBitcoin

Factuality

Ownership

The FDA will require further warnings for GLP-1 drugs for a possible association with a rare condition that can cause permanent loss of vision. The agency identified few cases and studies offer mixed results, so it has not been established that the drugs are the cause.

El Heraldo de Saltillo

Factuality

Ownership

Monterrey, NL.- Novo Nordisk A/S and Eli Lilly and Company pharmaceuticals should warn users of a possible rare side effect that may affect vision, following a new requirement from the U.S. Food and Drug Administration (FDA). The agency will require companies to manufacture treatments with agonists [...] Entry Alert for possible eye side effect of Ozempic, Wegovy and other drugs was first published in El Heraldo de Saltillo.

Quotidiano Nazionale

Factuality

Ownership

The alarm for several medicines: several cases reported to the FDA, which now urges to insert a new warning on the leaflets

yucatan.com.mx

Factuality

Ownership

After at least 4 documented cases, Novo Nordisk, the manufacturer of Ozempic and Wegovy; as well as Eli Lilly should warn consumers about a possible decrease in vision or loss of vision potentially permanent, as a side effect. This new requirement to popular medicines, useful to lose weight and against [...]